Research & Development



  說完,我用力甩手,像丟洋娃娃一樣扔開寧嘉,坐回沙發。彩票app下载送18元   青年點點頭,從腰間拔出手槍,頂住藍波的後心扣動扳機。砰砰砰三響,藍波的身體隨著震動三下,後背迅速染紅,腦袋耷拉下去。彩票棋牌app下载   肖軍平時的座駕是沃爾沃,換開面包車,一定想隱瞞行蹤。我又回憶起,在拉面店尋釁時,肖軍說有人看見我與藍波在一起,可明明是他親自撞上的。他是隨口一說,還是故意不讓兩名小弟知道那晚的遭遇?   我用手指挑起粉鑽項鏈,在她眼前晃。逼問藍波沒用那麼長時間,我又約了一個人,做了一些別的事,暫時不打算說出來。彩票开奖查询网站那个好   我拽出的是一截手臂。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo